Home

Trunk bibliotheek afbetalen olifant xarelto atrial fibrillation dose invoeren Uitgestorven Proportioneel

Target-Specific Oral Anticoagulants
Target-Specific Oral Anticoagulants

Life on a Blood Thinner: Insights and Advice from an Anticoagulant  Specialist - YouTube
Life on a Blood Thinner: Insights and Advice from an Anticoagulant Specialist - YouTube

Direct Oral Anticoagulants in Patients on Chronic Dialysis and Concomitant Atrial  Fibrillation: A Common Clinical Impasse
Direct Oral Anticoagulants in Patients on Chronic Dialysis and Concomitant Atrial Fibrillation: A Common Clinical Impasse

Xarelto® (rivaroxaban) Prescriber Guide Version 5
Xarelto® (rivaroxaban) Prescriber Guide Version 5

Real-world safety and effectiveness of rivaroxaban using Japan-specific  dosage during long-term follow-up in patients with atrial fibrillation:  XAPASS | PLOS ONE
Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS | PLOS ONE

Xarelto: Package Insert - Drugs.com
Xarelto: Package Insert - Drugs.com

Xarelto® rivaroxaban Prescriber Guide
Xarelto® rivaroxaban Prescriber Guide

Xarelto® - Dosing Guide
Xarelto® - Dosing Guide

Dosing - DVT & PE Initial Treatment | XARELTO® (rivaroxaban) HCP
Dosing - DVT & PE Initial Treatment | XARELTO® (rivaroxaban) HCP

Cureus | Appropriateness of Prescribing Rivaroxaban at King Khalid  University Hospital Riyadh | Article
Cureus | Appropriateness of Prescribing Rivaroxaban at King Khalid University Hospital Riyadh | Article

Dosing & Treatment Information | XARELTO® (rivaroxaban) HCP
Dosing & Treatment Information | XARELTO® (rivaroxaban) HCP

Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians  With Atrial Fibrillation | Journal of the American College of Cardiology
Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation | Journal of the American College of Cardiology

Xarelto Full Prescribing Information, Dosage & Side Effects | MIMS  Philippines
Xarelto Full Prescribing Information, Dosage & Side Effects | MIMS Philippines

Safety Profile - NVAF | XARELTO® (rivaroxaban) HCP
Safety Profile - NVAF | XARELTO® (rivaroxaban) HCP

CorConsult Rx - #Repost @ambcarerx ・・・ Oral Anticoagulants have many  chronic indications, most commonly VTE treatment/prophylaxis, atrial  fibrillation, and valvular heart disease. VTE & AF can both be treated with  either warfarin
CorConsult Rx - #Repost @ambcarerx ・・・ Oral Anticoagulants have many chronic indications, most commonly VTE treatment/prophylaxis, atrial fibrillation, and valvular heart disease. VTE & AF can both be treated with either warfarin

JCM | Free Full-Text | Direct Oral Anticoagulants in Patients with Obesity  and Atrial Fibrillation: Position Paper of Italian National Association of  Hospital Cardiologists (ANMCO)
JCM | Free Full-Text | Direct Oral Anticoagulants in Patients with Obesity and Atrial Fibrillation: Position Paper of Italian National Association of Hospital Cardiologists (ANMCO)

Remedial dosing recommendation for delayed or missed rivaroxaban doses for  patients with non-valvular atrial fibrillation based on Monte Carlo  simulation | medRxiv
Remedial dosing recommendation for delayed or missed rivaroxaban doses for patients with non-valvular atrial fibrillation based on Monte Carlo simulation | medRxiv

Xa Inhibitors - Apixaban and Rivaroxaban Oral Xa ... | GrepMed
Xa Inhibitors - Apixaban and Rivaroxaban Oral Xa ... | GrepMed

Direct Oral Anticoagulants - ppt video online download
Direct Oral Anticoagulants - ppt video online download

The New Oral Anticoagulants in Atrial Fibrillation: Once or Twice Daily? -  American College of Cardiology
The New Oral Anticoagulants in Atrial Fibrillation: Once or Twice Daily? - American College of Cardiology

XARELTO® for PE | XARELTO® (rivaroxaban)
XARELTO® for PE | XARELTO® (rivaroxaban)

Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended  Doses of Direct Oral Anticoagulants | Journal of the American College of  Cardiology
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants | Journal of the American College of Cardiology

Xarelto® - Dosing Guide
Xarelto® - Dosing Guide

Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial  Fibrillation and Renal Dysfunction - ScienceDirect
Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction - ScienceDirect

Clinical Risk Factors of Thromboembolic and Major Bleeding Events for  Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan -  ScienceDirect
Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan - ScienceDirect